Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons

Annals of the New York Academy of Sciences

Volumn 1199, Issue , 2010, Pages 186-193

  Tian, Feng ^a   Marini, Ann M ^b   Lipsky, Robert H ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Brain derived neurotrophic factor; Chromatin remodeling; Epigenetic modification; HDAC; Histone; TSA

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR 1; HISTONE DEACETYLASE 1; HISTONE H14; HISTONE H3; HISTONE H3ACK9; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; TRICHOSTATIN A; UNCLASSIFIED DRUG;

BRAIN NERVE CELL; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EXON; HIPPOCAMPUS; NERVE CELL CULTURE; PROTEIN EXPRESSION;

RATTUS;

EID: 77953998901     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05175.x     Document Type: Conference Paper

References (33)

1. Strahl, B.D. & C.D. Allis. 2000. The language of covalent histone modifications. Nature 403: 41-45.
2. Berger, S.L. 2007. The complex language of chromatin regulation during transcription. Nature 447: 407-412.
3. Kim, Y.B., M. Yoshida & S. Horinouchi. 1995. Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase. Ann. N.Y. Acad. Sci. 886: 200-203.
4. Seth, K.A. & J.A. Majzoub. 2001. Repressor element silencing transcription factor/neuron-restricitve silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. J. Biol. Chem. 276: 13917-13923.
5. Quivy, V. & C. Van Lint. 2002. Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system. Biochem. Pharmacol. 64: 925-934.
6. Vanhaecke, T., P. Papeleu, G. Elaut, et al. 2004. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr. Med. Chem. 11: 1629-1643.
7. McGowan, P.O., M.J. Meaney & M. Szyf. 2008. Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res. 1237: 12-24.
8. Thoenen, H. 1995. Neurotrophins and neuronal plasticity. Science 270: 593-598.
9. Katz, L. & C.J. Shatz. 1996. Synaptic activity and the construction of cortical circuits. Science 274: 1133-1138.
10. Lu, B. & A. Figurov. 1997. Role of neurotrophins in synapse development and plasticity. Rev. Neurosci. 8: 1-12.
11. Arancio,O.&M.V. Chao. 2007.Neurotrophins, synaptic plasticity and dementia. Curr. Opin. Neurobiol. 17: 325-330.
12. Marini, A.M., X. Jiang, X.Wu, et al. 2004. Role of BDNF and NF-κB in neuronal plasticity and survival: from genes to phenotype. Restor. Neurol. Neurosci. 22: 121-130.
13. Liu,Q.R.,D.Walther, T.Drgon, et al. 2005.Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's disease.Am. J.Med. Genet. B Neuropsychiatr. Genet. 134: 93-103.
14. Pruunsild, P., A. Kazantseva, T. Aid, et al. 2007. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, andmultiple promoters. Genomics 90: 397-406.
15. Jiang, X., J. Zhou, D.C.Mash, et al. 2008. Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution. Neuromolecular. Med. 11: 1559-11174
16. Aid, T., A. Kazantseva, M. Piirsoo, et al. 2007. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85: 525-535.
17. Huang, Y., J.J. Doherty & R. Dingledine. 2002. Altered histone acetylation at glutamate receptor 2 and brainderived neurotrophic factor genes is an early event triggered by status epilepticus. J. Neurosci. 22: 8422-8428.
18. Chen, W.G., Q. Chang, Y. Lin, et al. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885-889.
19. Martinowich, K., D. Hattori, H. Wu, et al. 2003. DNA methylation-related chromatin remodeling in activitydependent BDNF gene regulation. Science 302: 890-893.
20. Tsankova, N.M., O. Berton,W. Renthal, et al. 2006. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9: 519-525.
21. Cheng, B., K. Furukawa, J. A. O'Keefe, et al. 1995. Basic fibroblast growth factor selectively increases AMPAreceptor subunit GluR1 protein level and differentially modulates Ca2+ responses to AMPA and NMDA in hippocampal neurons. J. Neurochem. 65: 2525-2536.
22. Jiang, X., F. Tian, K. Mearow, et al. 2005. The excitoprotective effect of N-methyl-d-aspartate receptors ismediated by a brain-derived neurotrophic factor acutocrine loop in cultured hippocampal neurons. J. Neurochem. 94: 713-722.
23. Wu, X., D. Zhu, X. Jiang, et al. 2004. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphqatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression. J. Neurochem. 90: 807-818.
24. Mellor, J. 2006. Dynamic nucleosomes and gene transcription. Trends Genet. 22: 320-329.
25. Tian, F., A.M. Marini & R.H. Lipsky. 2009. NMDA receptor activation induces differential epigenetic modification of Bdnf promoters in hippocampal neurons. Amino Acids. PMID: 19565326.
26. Bredy,T.W.,H.Wu, C.Crego, et al. 2007.Histonemodification around individual BDNF promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem. 14: 268-276.
27. Nakayama, M., Y. Gahara, T. Kitamura, et al. 1994. Distinctive four promoters collectively direct expression of brain-derived neurotrophic factor gene. Brain Res. Mol. Brain Res. 21: 206-218.
28. Yasuda, S., M-H. Liang, Z. Marinova, et al. 2009. The mood stabilizers lithium and valproate selectively activate the promoter of brain-derived neurotrophic factor in neurons. Mol. Psychiatry 14: 51-59.
29. Schuettengruber, B., E. Simboeck, H. Khier, et al. 2003. Autoregulation of mouse histone deacetylase 1 expression. Mol. Cell Biol. 23: 6993-7004.
30. Castro, L.M., M. Gallant & L.P. Niles. 2005. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J. Neurochem. 95: 1227-1236.
31. Kim, B., L.M.R. Castro, S. Jawed, et al. 2008. Clinically relevant concentrations of valproic acid modulate melatonin MT1 receptor, HDAC and MECP2 mRNA expression in C6 glioma cells. Eur. J. Pharmacol. 589: 45-48.
32. Gray, S.G.&T.J. Ekstrom.1998. Effects of cell density and trichostatin A on the expression ofHDAC1 and p57Kip2 in Hep 3B cells. Biochem. Biophys. Res. Commun. 245: 423-427.
33. Hauser, C., B. Scheuttengruber, S. Bartl, et al. 2002. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol. Cell Biol. 22: 7820-7830.